Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said Friday
Participants achieved mean weight loss approaching or exceeding 20% at 48 weeks with higher doses
In other words, it is difficult to prove that these medications provide a direct benefit, rather than a secondary benefit from either weight loss or control of diabetes. He said more research is needed to determine if and how GLP-1 drugs can cause mood disturbances
It is injected once a week using a tiny needle similar to an insulin needle
Clinics in big cities often charge more than smaller towns
Peptide AOD 9604 is a modified form of amino acids 176-191 and was originally used as an anti-obesity drug